 |
[Alpha Biz=(Chicago) Reporter Kim Jisun] Daewon Pharmaceutical announced on the 19th that Baek In-hwan (photo) was newly appointed as the CEO.
With the appointment, President Baek and Vice Chairman Baek Seung-yeol will head the company, respectively, and Chairman Baek Seung-ho will step down from the management front.
Baek, the third-generation owner of Daewon Pharmaceutical, took office as president as of Jan. 1 last year, but the CEO was operated under the management system of founder Baek Boo-hyun's eldest son and second son, Chairman Baek Seung-ho and Vice Chairman Baek Seung-yeol.
President Baek took over the position of Chairman Baek Seung-ho, who was in charge of his father, and Daewon Pharmaceutical will be changed from brother management to uncle management system.
AlphaBIZ 김지선(stockmk2020@alphabiz.co.kr)
